Download PDF
Pharmacopsychiatry 2011; 44(2): 43-54
DOI: 10.1055/s-0031-1273759
Review

© Georg Thieme Verlag KG Stuttgart · New York

Usefulness of Atypical Antipsychotics and Choline Esterase Inhibitors in Delirium: A Review

S. Grover1 , S. K. Mattoo1 , N. Gupta2
  • 1Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, India
  • 2South Staffordshire Healthcare NHS Foundation Trust, Burton on Trent, United Kingdom
Further Information

Publication History

received 04.10.2010 revised 20.01.2011

accepted 02.02.2011

Publication Date:
10 March 2011 (online)

Also available at
    Permissions and Reprints

Abstract

Delirium is characterized by disturbances of consciousness, attention, cognition, perception, emotions, sleep, and psychomotor activity. Management of delirium involves ensuring safety, improving functioning, identifying and treating the illness underlying the delirium, and use of antipsychotics or benzodiazepines to control behavioural symptoms and prevent mortality. Haloperidol continues to be the most commonly used antipsychotic in delirium. However, in recent times data have emerged which suggest that atypical antipsychotics may be as efficacious as haloperidol in the treatment of delirium. This review intends to review the data with respect to usefulness of atypical antipsychotics in the treatment of delirium. Besides atypical antipsychotics, data with respect to another group of medications – cholinesterase inhibitors are also reviewed. Electronic and manual searches were conducted to identify all the relevant studies and case reports/case series. Evidence suggests that risperidone, olanzapine and quetiapine are as efficacious as haloperidol in the treatment of delirium but have lesser side effects. Data for other atypical antipsychotics are scarce. The data on cholinesterase inhibitors for treatment and prevention of delirium are beginning to accumulate, but do not seem to be convincing. Our review suggests that risperidone, olanzapine and quetiapine are good alternatives to haloperidol in the treatment of delirium.

References

  • 1 American Psychiatric Association . Practice guideline for the treatment of patients with delirium.  Am J Psychiatry. 1999;  156 1-20
    PubMedSearch in Google Scholar
  • 2 Lipowski ZJ. Delirium (acute confusional states).  JAMA. 1987;  258 1789-1792
    CrossrefPubMedSearch in Google Scholar
  • 3 Massie MJ, Holland J, Glass E. Delirium in terminally ill cancer patients.  Am J Psychiatry. 1983;  140 1048-1050
    PubMedSearch in Google Scholar
  • 4 Cole MG, Primeau FJ. Prognosis of delirium in elderly hospital patients.  CMAJ. 1993;  149 41-46
    PubMedSearch in Google Scholar
  • 5 Lacasse H, Perreault MM, Williamson DR. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients.  Ann Pharmacother. 2006;  40 1966-1973
    CrossrefPubMedSearch in Google Scholar
  • 6 Sipahimalani A, Sime RM, Masand PS. Treatment of delirium with risperidone.  Int J Geriatr Psychopharmacol. 1997;  1 24-26
    PubMedSearch in Google Scholar
  • 7 Liu CY, Juang YY, Liang HY. et al . Efficacy of risperidone in treating the hyperactive symptoms of delirium.  Int Clin Psychopharmacol. 2004;  19 165-168
    CrossrefPubMedSearch in Google Scholar
  • 8 Gupta N, Sharma P, Mattoo SK. Effectiveness of risperidone in delirium.  Can J Psychiatry. 2005;  50 75
    PubMedSearch in Google Scholar
  • 9 Miyaji S, Yamamoto K, Hoshino S. et al . Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients.  Psychiatry Clin Neurosci. 2007;  61 275-282
    CrossrefPubMedSearch in Google Scholar
  • 10 Mittal D, Jimerson NA, Neely EP. et al . Risperidone in the treatment of delirium: Results from a prospective open-label trial.  J Clin Psychiatry. 2004;  65 662-667
    CrossrefPubMedSearch in Google Scholar
  • 11 Horikawa N, Yamazaki T, Miyamoto K. et al . Treatment of delirium with risperidone: Results of a prospective open trial with 10 patients.  Gen Hosp Psychiatry. 2003;  25 289-292
    CrossrefPubMedSearch in Google Scholar
  • 12 Parellada E, Baeza I, Pablo JD. et al . Risperidone in the treatment of patients with delirium.  J Clin Psychiatry. 2004;  65 348-353
    CrossrefPubMedSearch in Google Scholar
  • 13 Toda H, Kusumi I, Sasaki Y. et al . Relationship between plasma concentration levels of risperidone and clinical effects in the treatment of delirium.  Int Clin Psychopharmacol. 2005;  20 331-333
    CrossrefPubMedSearch in Google Scholar
  • 14 Ikezawa K, Canuet L, Ishii R. et al . Efficacy of risperidone in the treatment of delirium in elderly patients.  Psychogeriatrics. 2008;  8 62-65
    CrossrefPubMedSearch in Google Scholar
  • 15 Kim JY, Jung IK, Han C. et al . Antipsychotics and dopamine transporter gene polymorphisms in delirium patients.  Psychiatry Clin Neurosci. 2005;  59 183-188
    CrossrefPubMedSearch in Google Scholar
  • 16 Han C, Kim Y. A double-blind trial of risperidone and haloperidol for the treatment of delirium.  Psychosomatics. 2004;  45 297-301
    CrossrefPubMedSearch in Google Scholar
  • 17 Sipahimalani A, Masand PS. Use of risperidone in delirium: case reports.  Ann Clin Psychiatry. 1997;  9 105-107
    CrossrefPubMedSearch in Google Scholar
  • 18 Bourgeois JA, Hilty DM. Prolonged delirium managed with risperidone.  Psychosomatics. 2005;  46 90-91
    CrossrefPubMedSearch in Google Scholar
  • 19 Okumura K. Risperidone therapy for post-operative delirium in elderly patients.  Psychogeriatrics. 2005;  5 108-111
    CrossrefPubMedSearch in Google Scholar
  • 20 Sipahimalani A, Masand PS. Olanzapine in the treatment of delirium.  Psychosomatics. 1998;  39 422-429
    CrossrefPubMedSearch in Google Scholar
  • 21 Kim K, Pae C, Chae J. et al . An open pilot trial of olanzapine for delirium in the Korean population.  Psychiatry Clin Neurosci. 2001;  55 515-519
    CrossrefPubMedSearch in Google Scholar
  • 22 Breitbart W, Tremblay A, Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients.  Psychosomatics. 2002;  43 175-182
    CrossrefPubMedSearch in Google Scholar
  • 23 Skrobik Y, Bergeron N, Dumont M. et al . Olanzapine vs. haloperidol: Treating delirium in a critical care setting.  Intens Care Med. 2004;  30 444-449
    CrossrefPubMedSearch in Google Scholar
  • 24 Hu H, Deng W, Yang H. A prospective random control study comparison of olanzapine and haloperidol in senile delirium.  Chongging Med J. 2004;  8 1234-1237
    PubMedSearch in Google Scholar
  • 25 Passik SD, Cooper M. Complicated delirium in a cancer patient successfully treated with olanzapine.  J Pain Symptom Manage. 1999;  17 219-223
    CrossrefPubMedSearch in Google Scholar
  • 26 Lee Y, Lee J, Rim HD. et al . A comparative study of haloperidol and quetiapine in the treatment of delirium: a preliminary randomized open label, flexible dose trial.  Eur Neuropsychopharmacol. 2006;  16 (S 04) S488-S489
    PubMedSearch in Google Scholar
  • 27 Maneeton B, Maneeton N, Srisurapanont M. An open-label study of quetiapine for delirium.  J Med Assoc Thai. 2007;  90 2158-2163
    PubMedSearch in Google Scholar
  • 28 Shinno H, Matsuoka T, Yamamoto O. et al . Successful treatment with quetiapine for delirium in terminally ill cancer patients.  Psychogeriatrics. 2007;  7 64-68
    CrossrefPubMedSearch in Google Scholar
  • 29 Omura K, Amano N. Clinical experience of quetiapine in 24 elderly patients with delirium.  Psychogeriatrics. 2003;  3 69-72
    CrossrefPubMedSearch in Google Scholar
  • 30 Sasaki Y, Matsuyama T, Inoue S. et al . A prospective, open label, flexible-dose study of quetiapine in the treatment of delirium.  J Clin Psychiatry. 2003;  64 1316-1321
    CrossrefPubMedSearch in Google Scholar
  • 31 Kim KY, Bader GM, Kotlyar V. et al . Treatment of delirium in older adults with quetiapine.  J Geriatr Psychiatry Neurol. 2003;  16 29-31
    CrossrefPubMedSearch in Google Scholar
  • 32 Schwartz TL, Masand PS. Treatment of delirium with quetiapine. Primary Care Companion.  J Clin Psychiatry. 2000;  2 10-12
    PubMedSearch in Google Scholar
  • 33 Lee KU, Won WY, Lee HK. et al . Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study.  Int Clin Psychopharmacol. 2005;  20 311-314
    CrossrefPubMedSearch in Google Scholar
  • 34 Pae CU, Lee SJ, Lee CU. et al . A pilot trial of quetiapine for the treatment of patients with delirium.  Human Psychopharmacol. 2004;  19 125-127
    PubMedSearch in Google Scholar
  • 35 Devlin JW, Roberts RJ, Fong JJ. et al . Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.  Crit Care Med. 2010;  38 419-427
    CrossrefPubMedSearch in Google Scholar
  • 36 Torres R, Mittal D, Kennedy R. Use of quetiapine in delirium: case reports.  Psychosomatics. 2001;  42 347-349
    CrossrefPubMedSearch in Google Scholar
  • 37 Al-Samarrai S, Dunn J, Newmark T. et al . Quetiapine for treatment-resistant delirium.  Psychosomatics. 2003;  44 350-351
    CrossrefPubMedSearch in Google Scholar
  • 38 Kato D, Kawanishi C, Kishida I. et al . Delirium resolving upon switching from risperidone to quetiapine: implication of CYP2D6 genotype.  Psychosomatics. 2005;  46 374-375
    CrossrefPubMedSearch in Google Scholar
  • 39 Seemüller F, Volkmer E, Vogel T. et al . Quetiapine as treatment for delirium during weaning from ventilation: a case report.  J Clin Psychopharmacol. 2007;  27 526-528
    CrossrefPubMedSearch in Google Scholar
  • 40 Takeuchi T, Furuta K, Hirasawa T. et al . Perospirone in the treatment of patients with delirium.  Psychiatry Clin Neurosc. 2007;  61 67-70
    PubMedSearch in Google Scholar
  • 41 Ushijima M, Yokoyama S, Sugiyama E. et al . Contribution of perospirone and risperidone to reduce delirium in senile patients.  Psychogeriatrics. 2008;  8 4-7
    CrossrefPubMedSearch in Google Scholar
  • 42 Leso L, Schwartz TL. Ziprasidone treatment of delirium.  Psychosomatics. 2002;  43 61-62
    CrossrefPubMedSearch in Google Scholar
  • 43 Young CC, Lujan E. Intravenous ziprasidone for treatment of delirium in the intensive care unit.  Anesthesiology. 2004;  101 794-795
    CrossrefPubMedSearch in Google Scholar
  • 44 Girard TD, Pandharipande PP, Carson SS. et al . MIND Trial Investigators Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial.  Crit Care Med. 2010;  38 428-437
    CrossrefPubMedSearch in Google Scholar
  • 45 Straker DA, Shapiro PA, Muskin PR. Aripiprazole in the treatment of delirium.  Psychosomatics. 2006;  47 385-391
    CrossrefPubMedSearch in Google Scholar
  • 46 Tarumi Y, Watanabe S. The potential role of zuclopenthixol acetate in the management of refractory hyperactive delirium at the end of Life.  J Pain Symptom Manage. 2008;  35 336-339
    CrossrefPubMedSearch in Google Scholar
  • 47 Wengel SP, Roccaforte WH, Burke WJ. Donepezil improves symptoms of delirium in dementia: implication for future research.  J Geriatr Psychiatry Neurol. 1998;  11 159-161
    PubMedSearch in Google Scholar
  • 48 Wengel SP, Burke WJ, Roccaforte WH. Donepezil for postoperative delirium associated with Alzheimer's disease (letter).  J Am Geriatr Soc. 1999;  47 379-380
    PubMedSearch in Google Scholar
  • 49 Kaufer DI, Catt KE, Lopez OL. et al . dementia with Lewy bodies: response of delirium-like features to donepezil.  Neurology. 1998;  51 1512
    PubMedSearch in Google Scholar
  • 50 Hori K, Tominaga I, Inada T. et al . Donepezil-responsive alcohol-related prolonged delirium.  Psychiatry Clin Neurosci. 2003;  57 603-604
    CrossrefPubMedSearch in Google Scholar
  • 51 Gleason OC. Donepezil for postoperative delirium.  Psychosomatics. 2003;  44 437-438
    CrossrefPubMedSearch in Google Scholar
  • 52 Noyan MA, Elbi H, Aksu H. Donepezil for anticholinergic drug intoxication.  Prog Neuro-Psychopharmacol Biol Psychiatry. 2003;  27 885-887
    CrossrefPubMedSearch in Google Scholar
  • 53 Kobayashi K, Higashima M, Mutou K. et al . Severe delirium due to basal forebrain vascular lesion and efficacy of donepezil.  Progr Neuro-Psychopharmacol Biol Psychiatry. 2004;  28 1189-1194
    CrossrefPubMedSearch in Google Scholar
  • 54 Logan CJ, Stewart JT. Treatment of post-electroconvulsive therapy delirium and agitation with donepezil.  J ECT. 2007;  23 28-29
    CrossrefPubMedSearch in Google Scholar
  • 55 Liptzin B, Laki A, Garb JL. et al . Donepezil in the prevention and treatment of post-surgical delirium.  Am J Geriatr Psychiatry. 2005;  13 1100-1106
    CrossrefPubMedSearch in Google Scholar
  • 56 Sampson EL, Raven PR, Ndhlovu PN. et al . A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement.  Int J Geriatr Psychiatry. 2007;  22 343-349
    CrossrefPubMedSearch in Google Scholar
  • 57 Powers JS, Decoskey D, Kahrilas PJ. Physostigmine for treatment of delirium tremens.  J. Clin. Pharmacol. 1981;  21 57-60
    PubMedSearch in Google Scholar
  • 58 Slatkin N, Rhiner M. Treatment of opioid-induced delirium with acetylcholinesterase Inhibitors.  J Pain Sympt Manage. 2004;  27 268-273
    CrossrefPubMedSearch in Google Scholar
  • 59 Goff DC, Garber HJ, Jenike MA. Partial resolution of ranitidine-associated delirium with physostigmine: case report.  J Clin Psychiatry. 1985;  46 400-401
    PubMedSearch in Google Scholar
  • 60 Schuster P, Gabriel E, Küfferle B. et al . Reversal by physostigmine of clozapine-induced delirium.  Clin Toxicol. 1977;  10 437-441
    CrossrefPubMedSearch in Google Scholar
  • 61 Stern TA. Continuous infusion of physostigmine in anticholinergic delirium: case report.  J Clin Psychiatry. 1983;  44 463-464
    PubMedSearch in Google Scholar
  • 62 Blitt CD, Petty WC. Reversal of lorazepam delirium by physostigmine.  Anesth Analges. 1975;  54 607-608
    PubMedSearch in Google Scholar
  • 63 Holinger PC, Klawans HL. Reversal of tricyclic-overdosage-induced central anticholinergic syndrome by physostigmine.  Am J Psychiatry. 1976;  133 1018-1023
    PubMedSearch in Google Scholar
  • 64 Chapin JW, Wingard DW. Physostigmine reversal of benzquinamide-induced delirium.  Anesthesiology. 1977;  46 364-365
    CrossrefPubMedSearch in Google Scholar
  • 65 Weizberg M, Su M, Mazzola JL. et al . Altered mental status from olanzapine overdose treated with physostigmine.  Clin Toxicol (Phila). 2006;  44 319-325
    CrossrefPubMedSearch in Google Scholar
  • 66 Heiser JF, Wilbert DE. Reversal of delirium induced by tricyclic antidepressant drugs with physostigmine.  Am J Psychiatry. 1974;  131 1275-1277
    PubMedSearch in Google Scholar
  • 67 Jost U, Schmid A, Ruppert M. [Physostigmine reversal of central anticholinergic syndrome induced by midazolam/fentanyl, benzoctamine/buprenorphine and etomidate/carticaine or by atropine/promethazine/pethidine for premedication? (author's transl)].  Anaesthesist. 1982;  31 21-24
    PubMedSearch in Google Scholar
  • 68 Jenike MA, Levy JC. Physostigmine reversal of cimetidine-induced delirium and agitation.  J Clin Psychopharmacol. 1983;  3 43-44
    PubMedSearch in Google Scholar
  • 69 Mendelson G. Reversal by physostigmine of delirium induced by ingestion of the flowers of the plant Datura stramonium.  Anesth Analges. 1976;  55 260
    PubMedSearch in Google Scholar
  • 70 Funk W, Hollnberger H, Geroldinger J. Physostigmine and anaesthesia emergence delirium in preschool children: a randomized blind trial.  Eur J Anaesthesiol. 2008;  25 37-42
    CrossrefPubMedSearch in Google Scholar
  • 71 Kalisvaart CJ, Boelaarts L, De Jonghe JFM. et al . Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine.  Ned Tijdschr Geneeskd. 2004;  148 1501-1504
    PubMedSearch in Google Scholar
  • 72 Moretti R, Torre P, Antonello R. et al . Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients.  Am J Alzheimer's Dis Other Dementias. 2004;  19 333-339
    PubMedSearch in Google Scholar
  • 73 Dautzenberg PL, Mulder LJ, Olde Rikkert MG. et al . Adding rivastigmine to antipsychotics in the treatment of a chronic delirium.  Age Ageing. 2004;  33 516-517
    CrossrefPubMedSearch in Google Scholar
  • 74 Gamberini M, Bolliger D, Lurati Buse GA. et al . Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery – a randomized controlled trial.  Crit Care Med. 2009;  37 1762-1768
    Search in Google Scholar
  • 75 Lonergan E, Britton AM, Luxenberg J. Antipsychotics for delirium.  Cochrane Database Syst Rev. 2007;  2 CD0055942
    PubMedSearch in Google Scholar

Correspondence

Dr. S. Grover

Department of Psychiatry

Postgraduate Institute of

Medical Education & Research

160012 Chandigarh

India

Phone: +91/172/275 6807

Fax: +91/172/274 4401

Fax: +91/172/274 5078

Email: drsandeepg2002@yahoo.com